Frazier Life Sciences Management, L.P. Silence Therapeutics PLC Transaction History
Frazier Life Sciences Management, L.P.
- $1.7 Billion
- Q2 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 1,148,591 shares of SLN stock, worth $17.5 Million. This represents 1.29% of its overall portfolio holdings.
Number of Shares
1,148,591
Previous 1,148,591
-0.0%
Holding current value
$17.5 Million
Previous $24.8 Million
12.04%
% of portfolio
1.29%
Previous 1.3%
Shares
2 transactions
Others Institutions Holding SLN
# of Institutions
68Shares Held
26.5MCall Options Held
0Put Options Held
0-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$46.2 Million7.16% of portfolio
-
Siren, L.L.C. New York, NY2.83MShares$43.2 Million2.57% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY2.66MShares$40.6 Million3.3% of portfolio
-
Redmile Group, LLC San Francisco, CA2.01MShares$30.7 Million2.5% of portfolio
-
Logos Global Management LP San Francisco, CA1.48MShares$22.5 Million2.63% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $547M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...